Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		15,966,053
Beginning balance at Dec. 31, 2023	$ 11,871,020	$ 15,966	$ 79,909,644	$ (68,054,590)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	240,007		240,007
Net loss	(3,667,797)			(3,667,797)
Ending balance (in shares) at Mar. 31, 2024		15,966,053
Ending balance at Mar. 31, 2024	8,443,230	$ 15,966	80,149,651	(71,722,387)
Beginning balance (in shares) at Dec. 31, 2023		15,966,053
Beginning balance at Dec. 31, 2023	11,871,020	$ 15,966	79,909,644	(68,054,590)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(23,382,196)
Ending balance (in shares) at Sep. 30, 2024		74,998,312
Ending balance at Sep. 30, 2024	83,857,617	$ 74,998	175,219,405	(91,436,786)
Beginning balance (in shares) at Mar. 31, 2024		15,966,053
Beginning balance at Mar. 31, 2024	8,443,230	$ 15,966	80,149,651	(71,722,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock and prefunded warrants, net of offering costs (in shares)		59,032,259
Sale of common stock and prefunded warrants, net of offering costs of $5,234,020	94,758,747	$ 59,032	94,699,715	0
Share-based compensation expense	157,037		157,037
Net loss	(2,254,506)			(2,254,506)
Ending balance (in shares) at Jun. 30, 2024		74,998,312
Ending balance at Jun. 30, 2024	101,104,508	$ 74,998	175,006,403	(73,976,893)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	213,002		213,002
Net loss	(17,459,893)			(17,459,893)
Ending balance (in shares) at Sep. 30, 2024		74,998,312
Ending balance at Sep. 30, 2024	$ 83,857,617	$ 74,998	175,219,405	(91,436,786)
Beginning balance (in shares) at Dec. 31, 2024	89,704,194	89,704,194
Beginning balance at Dec. 31, 2024	$ 95,266,262	$ 89,704	189,956,252	(94,779,694)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	293,717		293,717
Net loss	(4,577,261)			(4,577,261)
Ending balance (in shares) at Mar. 31, 2025		89,704,194
Ending balance at Mar. 31, 2025	$ 90,982,718	$ 89,704	190,249,969	(99,356,955)
Beginning balance (in shares) at Dec. 31, 2024	89,704,194	89,704,194
Beginning balance at Dec. 31, 2024	$ 95,266,262	$ 89,704	189,956,252	(94,779,694)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (23,098,008)
Ending balance (in shares) at Sep. 30, 2025	91,879,177	91,879,177
Ending balance at Sep. 30, 2025	$ 73,174,166	$ 91,879	190,959,989	(117,877,702)
Beginning balance (in shares) at Mar. 31, 2025		89,704,194
Beginning balance at Mar. 31, 2025	90,982,718	$ 89,704	190,249,969	(99,356,955)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	389,114		389,114
Net loss	(8,827,510)			(8,827,510)
Ending balance (in shares) at Jun. 30, 2025		89,704,194
Ending balance at Jun. 30, 2025	$ 82,544,322	$ 89,704	190,639,083	(108,184,465)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of pre-funded warrants from private placement (in shares)	2,174,983	2,174,983
Exercise of pre-funded warrants from private placement		$ 2,175	(2,175)
Share-based compensation expense	$ 323,081		323,081
Net loss	$ (9,693,237)			(9,693,237)
Ending balance (in shares) at Sep. 30, 2025	91,879,177	91,879,177
Ending balance at Sep. 30, 2025	$ 73,174,166	$ 91,879	$ 190,959,989	$ (117,877,702)